Inhaled Nintedanib (AP02) for the Treatment of IPF: Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses to Healthy Subjects and IPF Patients

Michelle Palacios, Stephen Pham, Mark Surber, Deepthi K. Nair, Felix A. Woodhead (2025). Poster presented at American Thoracic Society (ATS) Conference